Ingredion Incorporated (INGR) Stock Price & How to Invest

Last updated November 2026

Short answer

Ingredion is a corn wet miller in the middle of turning itself into a specialty ingredients company, and as of October 16, 2026 the stock changes hands near ~$98.50 for roughly ~10.7 times trailing earnings and ~9.4 times the midpoint of 2026 adjusted guidance, down ~10% year to date. The question a buyer is really taking a view on is whether the specialty mix shift, now backed by a ~$3.5 billion cash bid for Tate & Lyle, arrives faster than the leverage and the plant problems.

INGR stock price

As of 2026-11-16, Ingredion Incorporated (INGR) last closed at $92.96, down 13.1% over the past year. Over the past 52 weeks it has traded between $91.72 and $120.41.

INGR last close
$92.96
1 day
-1.25%
1 month
-5.08%
1 year
-13.12%
52-week range
$91.72 to $120.41
Last close
2026-11-16

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Ingredion Incorporated's investor relations page. Walnut is informational, not investment advice.

INGR key stats

At $92.96 on November 16, 2026, Ingredion Incorporated (INGR) has a market cap of $5.8B, a P/E of 10.5 on trailing earnings (9.0 on forward earnings) and a dividend yield of 3.57%. It next reports earnings around February 2, 2027 (estimated).

Market cap
$5.8B
P/E (trailing)
10.5
P/E (forward)
9.0
EPS (trailing 12 months)
$8.81
Price to book
1.3
Dividend yield
3.57%
Beta
0.62
Next earnings
around February 2, 2027 (estimated)

Market cap, P/E and yield are measured at the $92.96 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Ingredion Incorporated (INGR)?

The last two weeks for Ingredion Incorporated, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • INGR closed at $92.96 on November 16, 2026, up 0.2% over the past five trading days (from $92.78).
  • Ingredion Incorporated next reports quarterly results around February 2, 2027 (estimated).
  • On November 6, 2026, Ingredion Incorporated filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 5, 2026, Ingredion Incorporated filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 6, 2026, Stephens & Co. lowered its target to $100.00 from $105.00 (Equal-Weight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Ingredion Incorporated (INGR) latest quarter

Ingredion reported revenue of $1.8 billion for Q3 2026, down 1% from a year earlier (Ingredion, Nov 5, 2026).

Revenue
$1.8 billion
down 1% from a year earlier
Diluted EPS (GAAP)
$2.23
down 15% from a year earlier
Texture & Healthful Solutions
$610 million
up 1% from a year earlier

Source: Ingredion Q3 2026 results, Nov 5, 2026. Full earnings breakdown

What does Ingredion Incorporated (INGR) do?

Ingredion Incorporated grinds corn and other crops into starches, sweeteners and texturizing ingredients that end up inside packaged food, beverages, paper and pharmaceuticals. The business reports in three segments: Texture & Healthful Solutions, the global specialty texturant arm that produced ~$627 million of second quarter net sales; Food and Industrial Ingredients in Latin America, at ~$611 million; and Food and Industrial Ingredients in the US and Canada, at ~$488 million. A fourth bucket called All Other holds the PureCircle stevia, sugar reduction and pea protein fortification businesses. Trailing twelve month revenue runs about ~$7.2 billion on a market capitalisation near ~$6.2 billion as of October 2026, and the company has been reshaping the portfolio hard, closing its Cabo plant in Brazil and selling ~51% of its Pakistan subsidiary for ~$165 million in June 2026.

The investment picture in 2026 is two stories running in opposite directions. Specialty volumes are growing and the US commodity segment is not, with US and Canada operating income down ~48% in the first half after a thermal event at the Argo facility in Illinois cost volumes and added manufacturing expense. Meanwhile management agreed in June to buy Tate & Lyle for 595 pence a share in cash, roughly ~£2.7 billion, a deal Tate & Lyle shareholders approved in late July and which is not expected to complete until the second half of 2027. That combination, a depressed commodity year and a large levered acquisition still 12 months from closing, is why the shares trade at a discount to the ingredient companies Ingredion wants to be compared with, and why the reported multiple looks cheaper than the risk profile.

Since the second quarter report the stock has drifted lower. Second quarter adjusted EPS of ~$2.82 beat the ~$2.72 consensus, the first beat after three straight misses, but reported net income fell to ~$114 million from ~$142 million in the first quarter, and the shares closed at ~$98.52 on October 16, 2026, down ~10% year to date and ~18% over twelve months, close to the bottom of a ~$93.72 to ~$123.49 range. UBS trimmed its target to ~$104 from ~$108 in early October while keeping a neutral rating. Third quarter results are scheduled for November 5, 2026, with consensus near ~$2.61 of EPS on ~$1.8 billion of revenue, and the first read on whether Argo has normalised.

What's driving Ingredion Incorporated (INGR)?

1. Corn costs pass through, so revenue and profit move separately

Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. Latin America demonstrated the mechanic in the first half of 2026, where net sales rose ~2% on currency while price mix fell specifically because raw material input costs fell. Reading Ingredion's top line as a demand signal will mislead more often than it informs, and the useful line is segment operating income.

2. Texture & Healthful Solutions carries the mix shift

The specialty texturant segment grew second quarter net sales ~5% to ~$627 million and lifted operating income ~5% to ~$117 million, while the US and Canada commodity segment fell ~33% to ~$58 million over the same three months. Specialty ingredients earn higher and steadier margins than high fructose corn syrup, so every point of mix shift improves the quality of earnings even when consolidated revenue is flat. Inside All Other, the protein fortification and stevia businesses swung from a small loss to ~$9 million of operating income year to date.

3. Tate & Lyle is that mix shift bought outright

Announced on June 8, 2026 and approved by Tate & Lyle shareholders on July 28, the all cash offer values the target's equity at approximately ~£2.7 billion, or about ~$3.5 billion at the June 30 rate. Tate & Lyle reported ~£2.0 billion of continuing revenue for its year ended March 2026, concentrated in sugar reduction, fibre and fortification, areas where Ingredion is currently sub scale. Management expects pro forma net leverage near ~3.0x adjusted EBITDA at completion and has committed to getting back toward ~2.5x within roughly 18 months, with financing already arranged through a ~$2.75 billion bridge and a ~$1.48 billion delayed draw term loan.

4. Cash generation still funds the dividend, but not the buyback

The 2026 guide calls for ~$700 million to ~$800 million of operating cash flow against ~$450 million to ~$490 million of capital spending, and the quarterly dividend stepped up to ~$0.82 in January for a yield near ~3.4% at the October 2026 price on a payout ratio around ~36%. Repurchases have effectively stopped ahead of the acquisition: only ~120 thousand shares were bought back in the first half at a cost of ~$14 million, against an authorisation covering 8.0 million shares through 2028. First half operating cash flow of ~$123 million ran well below the ~$262 million of a year earlier, largely on receivables build.

What are the risks to Ingredion Incorporated (INGR)?

The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Funding Tate & Lyle takes net debt from roughly ~$0.8 billion today to about ~3.0x EBITDA at completion, and with closing not expected until the second half of 2027 there is a long window of antitrust review, integration planning and carrying cost before any synergy shows up. Second quarter financing costs jumped to ~$55 million mostly because of ~$47 million in hedging losses on the sterling consideration, so the currency exposure is already live even though the deal is not. Latin America supplies roughly a third of sales and carries Mexican peso translation risk plus what management called a more challenging demand environment. High fructose corn syrup consumption in North America is in slow secular decline, which the specialty growth has to outrun rather than merely offset. Analysts expect 2026 adjusted EPS of about ~$10.50, down ~6% on 2025, before a ~7% rebound to ~$11.25 in 2027, so the recovery case rests on the second half of this year.

What is the Ingredion Incorporated (INGR) forecast?

6 analysts publish price targets on INGR, averaging $113.17 as of November 2026, or +21.7% against the $92.96 share price on November 16, 2026. The published targets run from $100.00 to $135.00, a moderate spread, and the ratings split 2 buy, 5 hold, 0 sell. Over the last six months there has been 1 raise and 5 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full INGR forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is INGR a buy or a sell?

We give no verdict on Ingredion Incorporated. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Corn costs pass through, so revenue and profit move separately. Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. The most optimistic published target, $135.00, assumes this works close to its best case.

The case against. The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. The most pessimistic target, $100.00, is roughly what INGR is worth if this bites instead.

Read the full bull and bear case on INGR, including what would have to change to break either one. Walnut is not an investment adviser.

Has Ingredion Incorporated (INGR) split its stock?

No. Ingredion Incorporated (INGR) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Ingredion Incorporated (INGR) valued?

Market cap, P/E and dividend yield at today's price are in the INGR key stats above. The business figures below come from Ingredion Incorporated's reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$7.2B (Q2 up ~1% YoY)
  • Net income (TTM): ~$592M (EPS ~$9.20)
  • Margins (gross / operating): ~23.7% / ~12.6%
  • FY 2026 adjusted EPS guidance: ~$10.30 to ~$10.90
  • Cash / debt (pre acquisition): ~$1.0B / ~$1.8B

As of October 2026: Near ~$98.50 a share on October 16, 2026 the stock carries about ~10.7 times trailing earnings, roughly ~9.4 times the midpoint of 2026 adjusted guidance and ~8.8 times next year's consensus, a visible discount to the branded specialty ingredient houses. That gap prices the commodity half of the business, the Argo disruption and the leverage still to arrive; the six covering analysts sit at hold with a mean target near ~$119.50. Reported and adjusted earnings diverge unusually far this year because of the Cabo closure charges, the ~$44 million Pakistan disposal gain and the acquisition hedges, so the ~$9.15 to ~$9.75 reported guide sits well below the ~$10.30 to ~$10.90 adjusted one.

Who competes with Ingredion Incorporated (INGR)?

Corn wet millers and agricultural processors

Archer Daniels Midland, privately held Cargill, France's Tereos and Grain Processing Corporation compete directly in starches, sweeteners and industrial corn products. These are the businesses that set pricing in Ingredion's US and Canada and Latin America segments, where contracts pass net corn costs through and competition is fought on plant efficiency and freight rather than formulation.

Specialty ingredient and texturant houses

Kerry Group, International Flavors & Fragrances, Roquette, Givaudan, Sensient Technologies and Ashland sell into the same formulation conversations that Texture & Healthful Solutions targets. Tate & Lyle belongs on this list until the acquisition completes, at which point the overlap becomes an internal question rather than a competitive one.

Sugar reduction and plant protein specialists

Sweegen, Puris and Cargill's stevia venture compete against Ingredion's PureCircle and pea protein lines, the smallest but fastest moving part of the portfolio. This is also where the strategic logic of Tate & Lyle sits, since sugar reduction and fibre are exactly where the target is strong and Ingredion is not.

What stocks are similar to Ingredion Incorporated (INGR)?

Other names that sit close to INGR: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Ingredion Incorporated (INGR)

There are three common ways to get INGR exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so INGR sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where INGR fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Ingredion Incorporated (INGR)

INGR prices like a commodity processor while spending like a specialty ingredients company, and the next two years decide which description fits. With the shares down ~18% over the past year and third quarter results due November 5, 2026, the market is still pricing the commodity half.

More on Ingredion Incorporated (INGR)

Whether INGR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is INGR a buy or a sell?, and where the stock could go from here in the INGR stock forecast.

For income investors, whether INGR pays a dividend and how the payout looks is covered in does INGR pay a dividend? And to weigh INGR against a peer, read the full side-by-side comparisons: INGR vs IFF and INGR vs SXT.

Wondering how INGR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Ingredion Incorporated

Ask Walnut's AI anything about INGR and see how it fits what you own.

FAQ

What does Ingredion actually make?

+

It processes corn and other crops into starches, sweeteners, texturizers and nutrition ingredients that go into packaged food, drinks, paper, adhesives and pharmaceuticals. Very little of it reaches a shelf under the Ingredion name. Customers are food and beverage manufacturers who buy on contract.

Why did revenue stay flat while profit fell in the first half of 2026?

+

Net sales were ~$3,642 million against ~$3,646 million a year earlier, but cost of sales rose ~4% on higher manufacturing costs and the Argo thermal event, pushing gross margin from ~26% to ~23%. Restructuring charges of ~$56 million tied to the Cabo, Brazil closure and ~$47 million of acquisition hedging losses did the rest. Net income attributable to Ingredion fell to ~$256 million from ~$393 million.

How exposed is Ingredion to corn prices?

+

Less than the raw material intensity suggests. Core sweetener and starch contracts pass net corn costs through to customers, so corn moves the revenue line in both directions without much effect on gross profit. What corn does influence is working capital and hedging, and the company runs commodity cash flow hedges against it.

What is the Tate & Lyle acquisition and when does it close?

+

Ingredion agreed on June 8, 2026 to acquire Tate & Lyle for 595 pence per share in cash, valuing the equity at roughly ~£2.7 billion or about ~$3.5 billion. Tate & Lyle shareholders accepted on July 28, 2026. It is structured as a UK scheme of arrangement and management expects completion in the second half of 2027.

How will Ingredion pay for it?

+

Through existing cash, a ~$2.75 billion 364 day bridge facility, a ~$1.48 billion delayed draw term loan and debt securities it intends to issue. There is no financing condition on the deal. Pro forma net leverage is expected near ~3.0x adjusted EBITDA at completion, with a stated path back to about ~2.5x within roughly 18 months.

What happened at the Argo facility?

+

A thermal event at the Illinois plant caused production challenges that reduced volumes and raised manufacturing costs through the first half of 2026. Food and Industrial Ingredients in the US and Canada saw net sales fall ~8% to ~$963 million year to date and segment operating income drop ~48% to ~$92 million. It is the single largest reason consolidated margins compressed this year.

Does Ingredion pay a dividend?

+

Yes. The quarterly rate rose to ~$0.82 per share with the January 2026 payment, giving an annual rate of ~$3.28 and a yield near ~3.4% at the ~$98.50 share price of mid-October 2026. The payout ratio sits around ~36%, and dividends plus non controlling payments consumed ~$105 million of cash in the first half.

How did Ingredion do in its latest quarter?

+

In the second quarter of 2026 Ingredion reported net sales of ~$1.85 billion, up ~1% year over year, and adjusted EPS of ~$2.82 against a ~$2.72 consensus, its first beat after three quarters of small misses. Reported net income was ~$114 million, held down by Argo costs, Cabo restructuring and ~$47 million of sterling hedging losses tied to Tate & Lyle. Full year adjusted guidance was reaffirmed, and third quarter results are due November 5, 2026.

How has INGR stock performed in 2026?

+

INGR closed at ~$98.52 on October 16, 2026, down ~10% year to date and ~18% over the past year, near the low end of its 52 week range of ~$93.72 to ~$123.49. The slide reflects the Argo disruption, lower first half earnings and the leverage the Tate & Lyle deal will add. Analysts' mean target is ~$119.50, with UBS at ~$104.

What are the main things to watch in INGR from here?

+

Whether Argo volumes normalise and gross margin recovers toward the mid twenties, whether Texture & Healthful Solutions keeps compounding volume, and how antitrust review of Tate & Lyle progresses through 2027. Full year adjusted EPS guidance of ~$10.30 to ~$10.90 was reaffirmed with the second quarter, so a change there at the November 5, 2026 third quarter report would be the clearest signal. Leverage at completion is the other number worth tracking.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Ingredion Incorporated's investor relations page or your broker before making investment decisions.